S Linder Selected Research

S Linder Research Topics

Disease

11	Neoplasms (Cancer) 11/2016 - 01/2000
7	Carcinoma (Carcinomatosis) 08/2010 - 01/2000
5	Breast Neoplasms (Breast Cancer) 10/2013 - 07/2000
3	Adenocarcinoma 06/2006 - 01/2000
2	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 06/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2007 - 09/2001
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2003 - 02/2001
2	Neoplasm Metastasis (Metastasis) 09/2001 - 04/2000
2	Melanoma (Melanoma, Malignant) 06/2001 - 06/2001
1	Appendicitis 01/2019
1	Hernia (Hernias) 01/2019
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2016
1	Lymphatic Metastasis 10/2013
1	Necrosis 08/2010
1	Glioblastoma (Glioblastoma Multiforme) 03/2008
1	Glioma (Gliomas) 03/2008
1	Inguinal Hernia (Direct Inguinal Hernia) 04/2007
1	Obesity 04/2007
1	Endometrial Neoplasms (Endometrial Cancer) 10/2005
1	Adenocarcinoma of Lung 04/2003
1	Pathologic Constriction (Stenosis) 03/2001
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2001
1	Cholestasis 03/2001
1	Cholangitis 03/2001
1	Sclerosing Cholangitis 03/2001
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2001
1	Wiskott-Aldrich Syndrome 07/2000

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2003 - 01/2000
4	Peptides (Polypeptides)IBA 06/2000 - 01/2000
3	CaspasesIBA 01/2009 - 06/2001
3	Keratin-18 (Keratin 18)IBA 01/2009 - 01/2000
3	Messenger RNA (mRNA)IBA 04/2003 - 02/2000
2	Biomarkers (Surrogate Marker)IBA 01/2009 - 06/2006
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2001 - 02/2001
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2000 - 01/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	enzalutamideIBA 11/2018
1	VLX1570IBA 11/2016
1	Deubiquitinating EnzymesIBA 11/2016
1	Bortezomib (Velcade)FDA Link 11/2016
1	ibrutinibIBA 11/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2016
1	Tamoxifen FDA LinkGeneric 10/2013
1	DiosgeninIBA 08/2010
1	CarbohydratesIBA 08/2010
1	SteroidsIBA 08/2010
1	EpitopesIBA 01/2009
1	Small Interfering RNA (siRNA)IBA 03/2008
1	Hormones (Hormone)IBA 06/2006
1	Docetaxel (Taxotere)FDA Link 06/2006
1	theasinensin AIBA 06/2006
1	K-18 conjugate (K18)IBA 10/2005
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 04/2003
1	IgA receptor (protein B)IBA 04/2003
1	Surface-Active Agents (Surfactants)IBA 04/2003
1	Aspartic Acid ProteasesIBA 04/2003
1	ImmunosorbentsIBA 04/2003
1	EnzymesIBA 04/2003
1	Laminin (Merosin)IBA 09/2001
1	TenascinIBA 09/2001
1	Integrin alpha6IBA 09/2001
1	Cadherins (E-Cadherin)IBA 09/2001
1	IntegrinsIBA 09/2001
1	Collagen Type IV (Type IV Collagen)IBA 09/2001
1	Extracellular Matrix ProteinsIBA 09/2001
1	Cell Surface ReceptorsIBA 09/2001
1	VitronectinIBA 09/2001
1	Laminin ReceptorsIBA 09/2001
1	AntigensIBA 07/2001
1	Plasminogen Activator Inhibitor 1IBA 07/2001
1	Codon (Codons)IBA 06/2001
1	Cisplatin (Platino)FDA LinkGeneric 06/2001
1	Arginine (L-Arginine)FDA Link 06/2001
1	CytokinesIBA 02/2001
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2001
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 02/2001
1	Cytostatic AgentsIBA 02/2001
1	polyacrylamideIBA 02/2001
1	KalininIBA 01/2001
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 07/2000
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 07/2000
1	Mitogen-Activated Protein Kinase 3IBA 07/2000
1	Phosphotransferases (Kinase)IBA 07/2000
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2000
1	Biological ProductsIBA 05/2000
1	TropomyosinIBA 04/2000
1	RNA (Ribonucleic Acid)IBA 04/2000
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2000
1	ProteomeIBA 04/2000
1	Keratins (Keratin)IBA 04/2000
1	StathminIBA 01/2000

Therapy/Procedure

4	Therapeutics 10/2013 - 02/2001
1	Laparotomy 01/2019
1	Adjuvant Chemotherapy 10/2013
1	Minor Surgical Procedures (Minor Surgery) 04/2007
1	Length of Stay 04/2007
1	Drug Therapy (Chemotherapy) 06/2006
1	Prostheses and Implants (Prosthesis) 03/2001
1	Lasers (Laser) 02/2001
1	Catheters 01/2001